Abbott Bypasses Appeals Process To Settle Ongoing Premature Infant Formula Litigation
Abbott agreed to pay $670 million to resolve the Gill lawsuit and 2,000 other NEC claims involving its specialty preterm infant formulas.
Abbott is paying $670 million to settle lawsuits about baby formula that may have made premature babies sick. When a company pays a big settlement, it shows they want to move past a problem, which can help investors understand what risks they've faced.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.